su5402 cs-0200 (ChemScene llc)
90
Structured Review
ChemScene llc
su5402 cs-0200
Su5402 Cs 0200, supplied by ChemScene llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402+cs-0200/su5402+cs+0200/pm38984461-171-109-111
Average 90 stars, based on 1 article reviews
Su5402 Cs 0200, supplied by ChemScene llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/su5402+cs-0200/su5402+cs+0200/pm38984461-171-109-111
Average 90 stars, based on 1 article reviews
su5402 cs-0200 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Control:Article Title: BMP4 regulates asymmetric Pkd2 distribution in mouse nodal immotile cilia and ciliary mechanosensing required for left-right determination. Article Snippet: Agents were added to the medium at final concentrations of 1 μg/mL for BMP4 treatment (314-BP; R&D Systems, Minneapolis, MN, USA), 1% v/v of 4 mM HCl containing 0.1% bovine serum albumin (BSA; A3311; Sigma-Aldrich, St. Louis, MO, USA) as the control of BMP4 treatment, 1 μg/mL for Noggin treatment (1967-NG; R&D Systems), 1% v/v of phosphate-buffered saline (PBS) containing 0.1% BSA as the control of Noggin treatment, 1 μg/mL Noggin and 1 μg/mL Chordin as double treatment (758-CN; R&D Systems), 2% v/v of PBS containing 0.1% BSA as the control Noggin and Chordin double treatment, 200 μM for DAPT (AG-CR1-0016; AdipoGen, San Diego, CA, USA), 25 μM for Saline:Article Title: BMP4 regulates asymmetric Pkd2 distribution in mouse nodal immotile cilia and ciliary mechanosensing required for left-right determination. Article Snippet: Agents were added to the medium at final concentrations of 1 μg/mL for BMP4 treatment (314-BP; R&D Systems, Minneapolis, MN, USA), 1% v/v of 4 mM HCl containing 0.1% bovine serum albumin (BSA; A3311; Sigma-Aldrich, St. Louis, MO, USA) as the control of BMP4 treatment, 1 μg/mL for Noggin treatment (1967-NG; R&D Systems), 1% v/v of phosphate-buffered saline (PBS) containing 0.1% BSA as the control of Noggin treatment, 1 μg/mL Noggin and 1 μg/mL Chordin as double treatment (758-CN; R&D Systems), 2% v/v of PBS containing 0.1% BSA as the control Noggin and Chordin double treatment, 200 μM for DAPT (AG-CR1-0016; AdipoGen, San Diego, CA, USA), 25 μM for |